Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Center for Advancing Translational Sciences Advisory Council.

The meeting will be open to the public as indicated below, viewing virtually by WebEx. Individuals can register to view and access the meeting by the links below:

*January 14, 2021 WebEx: https://nih.webex.com/​nih/​onstage/​g.php?​MTID=​efd5d81157ca86678111c546ced7a91fa*.                

*January 15, 2021 WebEx: https://nih.webex.com/​nih/​onstage/​g.php?​MTID=​eda63cdefa13a124ac49e7cffdac33aac*.                

1. Go to “Event Status” on the left-hand side of page, then click “Register”. On the registration form, enter your information and then click “Submit” to complete the required registration.

2. You will receive a personalized email with the live event link.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Advancing Translational Sciences Advisory Council.                    

*Date:*                         January 14-15, 2021.                    

*Closed:*                         January 14, 2021, 11:00 a.m. to 12:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, One Democracy Plaza, 9th Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Open:*                         January 14, 2021, 1:00 p.m. to 4:00 p.m.                    

*Agenda:*                         Report from the Institute Director and other staff.                    

*Place:*                         National Institutes of Health, One Democracy Plaza, 9th Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Open:*                         January 15, 2021, 1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To view and discuss Clearance of Concepts.                              ( print page 81215)    

*Place:*                         National Institutes of Health, One Democracy Plaza, 9th Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, One Democracy Plaza, Room 1072, Bethesda, MD 20892, (301) 435-0809,                         *anna.ramseyewing@nih.gov*.                    

                        Attendees and interested parties may submit questions and comments through written Q&A during the meeting, and for 15 days after the meeting, to                         *NCATSCouncilInput@mail.nih.gov*.                    

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 15 days after the meeting. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS).

Dated: December 10, 2020.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2020-27547 Filed 12-14-20; 8:45 am]

BILLING CODE 4140-01-P